Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center

Abstract

Introduction

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that can vary among different ethnic and racial groups.

Objective

The objective of this paper is to study the prevalence of various manifestations of SLE in a sample of the Egyptian population.

Patients and methods

Information in this study was derived from the medical records of SLE patients who sought medical advice at a private clinic in Cairo from January 1980 to June 2016.

Results

This study included 1109 SLE patients, of whom 114 (10.3%) were males and 995 were females (89.7%). Mean age of onset was 25.89 ± 10.81 years, while the median of disease duration from the onset of the disease till the last recorded visit was 26 months. The most common cumulative manifestations were arthritis (76.7%), malar rash (48.5%), leukopenia (45.7%), and photosensitivity (45.6%). A total of 33.1% of the patients had nephritis, and neuropsychiatric lupus was present in 6.4% of the patients. Secondary antiphospholipid syndrome was present in 11.5% of the patients. Antinuclear antibody and anti-double-stranded deoxyribonucleic acid were present in 1060/1094 (96.9%) and 842/1062 (79.3%) of the patients, respectively. Antiphospholipid antibodies were present in 266/636 (41.8%) of the patients, anti-Smith in 54/240 (22.5%), anti-SSA/Ro in 61/229 (20.4%), and anti-SSB/La in 32/277 (11.6%) of the patients. Male patients had a statistically higher prevalence of nephritis (p = 0.01), whereas arthritis and alopecia were statistically higher in females (p = 0.012 and p = 0.006, respectively). Patients with juvenile onset had a statistically higher prevalence of nephritis and seizures (p < 0.001 and p = 0.012, respectively).

Conclusions

Arthritis and malar rash represented the most common clinical manifestations. Male and juvenile-onset patients had a predilection toward a more severe disease. These results are in agreement with many studies conducted in the Middle East and worldwide. On the other hand, major organ involvement was exceptionally low, which is contradictory to several reports from the Middle East and across the globe.

Keywords

Antiphospholipid Systemic lupus erythematosus Egyptian characteristics juvenile

Get full access to this article

View all access options for this article.

References

Vilá

Alarcón

McGwin

Jr et al.

Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 2004; 43: 358–363.

Cervera

Khamashta

Font

et al.

Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 1993; 72: 113–124.

Alarcón

Friedman

Straaton

et al.

Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus 1999; 8: 197–209.

Alarcón

McGwin

Jr Petri

et al.

Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95–101.

Pons-Estel

Catoggio

Cardiel

et al.

The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Medicine (Baltimore) 2004; 83: 1–17.

Zhang

Leng

et al.

Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus 2013; 22: 1192–1199.

Uthman

Nasr

Kassak

Masri

. Systemic lupus erythematosus in Lebanon. Lupus 1999; 8: 713–715.

AlSaleh

Jassim

ElSayed

Saleh

Harb

. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus 2008; 17: 62–66.

Al Arfaj

Khalil

. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009; 18: 465–473.

10.

Akbarian

Faezi

Gharibdoost

et al.

Systemic lupus erythematosus in Iran: A study of 2280 patients over 33 years. Int J Rheum Dis 2010; 13: 374–379.

11.

Khanfir

Houman

Cherif

et al.

TULUP (TUnisian LUPus): A multicentric study of systemic lupus erythematosus in Tunisia. Int J Rheum Dis 2013; 16: 539–546.

12.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

13.

Petri

Orbai

Alarcón

et al.

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

14.

World Health Organization. Obesity: Preventing and managing the global epidemic, Geneva: World Health Organization, 2000.

15.

Miyakis

Lockshin

Atsumi

et al.

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemos 2006; 4: 295–306.

16.

Marton

Sox

Jr Krupp

. Involuntary weight loss: Diagnostic and prognostic significance. Ann Intern Med 1981; 95: 568–574.

17.

Lewis

Jawad

. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2017; 56(Suppl 1): i67–i77.

18.

Houman

Smiti-Khanfir

Ben Ghorbell

Miled

. Systemic lupus erythematosus in Tunisia: Demographic and clinical analysis of 100 patients. Lupus 2004; 13: 204–211.

19.

Nazarinia

Ghaffarpasand

Shamsdin

Karimi

Abbasi

Amiri

. Systemic lupus erythematosus in the Fars Province of Iran. Lupus 2008; 17: 221–227.

20.

Yin

Zhang

. Clinical and immunological characteristics in 552 systemic lupus erythematosus patients in a southern province of China. Int J Rheum Dis 2017; 20: 68–75.

21.

Al-Jarallah

Al-Awadi

Siddiqui

et al.

Systemic lupus erythematosus in Kuwait—hospital based study. Lupus 1998; 7: 434–438.

22.

Cervera

Abarca-Costalago

Abramovicz

et al.

Lessons from the “Euro-Lupus Cohort”. Ann Med Interne (Paris) 2002; 153: 530–536.

23.

Al-Maini

El-Ageb

Al-Wahaibi

Al-Farsi

Richens

. Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol Int 2003; 23: 186–191.

24.

Petri

. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145–151.

25.

Cervera

Piette

Font

et al.

Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019–1027.

26.

Tselios

Koumaras

Gladman

Urowitz

. Dyslipidemia in systemic lupus erythematosus: Just another comorbidity? Semin Arthritis Rheum 2016; 45: 604–610.

27.

Hinojosa-Azaola

Romero-Diaz

Vargas-Ruiz

et al.

Venous and arterial thrombotic events in systemic lupus erythematosus. J Rheumatol 2016; 43: 576–586.

28.

Mok

Tang

Petri

. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups. Arthritis Rheum 2005; 52: 2774–2782.

29.

Budhoo

Mody

Dubula

Patel

Mody

. Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus. Lupus 2017; 26: 438–446.

30.

Zhang

et al.

Chinese SLE Treatment and Research group (CSTAR) registry: V. Gender impact on Chinese patients with systemic lupus erythematosus. Lupus 2015; 24: 1267–1275.

31.

Tan

Fang

Magder

Petri

. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012; 39: 759–769.

32.

Garcia

Marcos

et al.

Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005; 14: 938–946.

33.

das Chagas Medeiros

Bezerra

Braga

et al.

Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): Comparison between childhood-onset, adult-onset, and late-onset SLE. Lupus 2016; 25: 355–363.

34.

Morgan

Watson

McCann

Beresford

. Children and adolescents with SLE: Not just little adults. Lupus 2013; 22: 1309–1319.

35.

Joo

Park

Won

Bae

. Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: A prospective single-center study. J Rheumatol 2016; 43: 1490–1497.

36.

Ambrose

Morgan

Galloway

Ionnoau

Beresford

Isenberg

. Differences in disease phenotype and severity in SLE across age groups. Lupus 2016; 25: 1542–1550.

37.

Ramírez Gómez

Uribe Uribe

Osio Uribe

et al.

Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus 2008; 17: 596–604.

38.

Gheita

Fawzy

El-din

El-Fishawy

. Juvenile and adult onset systemic lupus erythematosus outcome in Egyptian patients. The Egyptian Rheumatologist 2011; 33: 99–105.

39.

Mohamed DF, Aziz AB, Hassan SA, Shedid NH, El-Owaidy RH, Teama MA. Juvenile lupus: Different clinical and serological presentations compared to adult lupus in Egypt. The Egyptian Rheumatologist. Epub ahead of print 12 April 2017. DOI: 10.1016/j.ejr.2017.04.004.

40.

Salah

Lotfy

Sabry

El Hamshary

Taher

. Systemic lupus erythematosus in Egyptian children. Rheumatol Int 2009; 29: 1463–1468.

41.

Abdel-Hafez

Abdel-Nabi

. Juvenile systemic lupus erythematosus: Onset patterns and short-term outcome in Egyptian children, a single-center experience. Lupus 2015; 24: 1455–1461.

42.

Khan WA. Introductory chapter: Systemic lupus erythematosus—different predisposing factors. In: Khan WA (ed.) Lupus. InTech, DOI:10.5772/intechopen.69277.

43.

Somers

Richardson

. Environmental exposures, epigenetic changes and the risk of lupus. Lupus 2014; 23: 568–576.